OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.320
-0.030 (-2.22%)
At close: Aug 6, 2026, 4:00 PM EDT
1.320
0.00 (0.00%)
Pre-market: Aug 7, 2026, 7:35 AM EDT

OPKO Health Revenue

OPKO Health had revenue of $163.58M in the quarter ending June 30, 2026, with 4.32% growth. This brings the company's revenue in the last twelve months to $439.45M, down -33.82% year-over-year. In the year 2025, OPKO Health had annual revenue of $606.90M, down -14.90%.

Revenue (ttm)
$439.45M
Revenue Growth
-33.82%
P/S Ratio
1.68
Revenue / Employee
$258,416
Employees
2,275
Market Cap
985.15M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025606.90M-106.24M-14.90%
Dec 31, 2024713.14M-150.35M-17.41%
Dec 31, 2023863.50M-140.70M-14.01%
Dec 31, 20221.00B-770.52M-43.42%
Dec 31, 20211.77B339.31M23.64%
Dec 31, 20201.44B533.48M59.15%
Dec 31, 2019901.94M-88.33M-8.92%
Dec 31, 2018990.27M24.26M2.51%
Dec 31, 2017966.01M-151.49M-13.56%
Dec 31, 20161.12B625.76M127.25%
Dec 31, 2015491.74M400.61M439.63%
Dec 31, 201491.13M-5.41M-5.60%
Dec 31, 201396.53M49.49M105.19%
Dec 31, 201247.04M19.07M68.14%
Dec 31, 201127.98M-515.00K-1.81%
Dec 31, 201028.49M24.08M544.95%
Dec 31, 20094.42M-5.02M-53.20%
Dec 31, 20089.44M8.59M1,014.52%
Dec 31, 2007847.00K--
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Myriad Genetics806.60M
NeoGenomics766.30M
Veracyte561.90M
CareDx458.09M
GeneDx Holdings454.43M
Castle Biosciences357.28M
Fulgent Genetics323.93M
Adaptive Biotechnologies308.08M
Revenue Rankings